COMPARATIVE STUDY OF CISATRACURIUM AND ATRACURIUM IN DIFFERENT DOSES FOR INTUBATION DURING GENERAL ANESTHESIA IN LOWER ABDOMINAL SURGERY: A PROSPECTIVE RANDOMIZED DOUBLE-BLIND INTERVENTIONAL TRIAL

VEERENDRA SINGH GURJAR; TARUN LALL; SURENDRA MEENA

doi:10.22159/ijcpr.2023v15i4.3026

Authors

VEERENDRA SINGH GURJAR Department of Anesthesia, SMS Medical College, Jaipur, India
TARUN LALL Department of Anesthesia, SMS Medical College, Jaipur, India
SURENDRA MEENA Department of Anesthesia, SMS Medical College, Jaipur, India

DOI:

https://doi.org/10.22159/ijcpr.2023v15i4.3026

Keywords:

General anesthesia, Endotracheal intubation, Neuromuscular blocking agents

Abstract

Objective: General anesthesia requires smooth endotracheal intubation, aided by neuromuscular blocking agents. Atracurium and cis-atracurium are non-depolarizing agents used for muscle relaxation. Succinylcholine, though effective, has undesirable side effects. This study aims to compare atracurium and different doses of cis-atracurium to assess their onset, duration, recovery, hemodynamic effects, and side effects, in order to identify the ideal agent for intubation.

Methods: The study will compare atracurium (0.5 mg/kg) with two different doses of cis-atracurium, namely 0.10 mg/kg and 0.15 mg/kg. The parameters evaluated will include the onset of neuromuscular blockade, duration of blockade, recovery time, hemodynamic effects, and incidence of side effects. Neuromuscular monitoring will be employed to ensure proper dosing and prevent residual paralysis.

Results: The study will provide valuable data on the comparative characteristics of atracurium and cis-atracurium at different doses. This includes their onset of action, duration of neuromuscular blockade, recovery time, impact on hemodynamic parameters, and occurrence of side effects. The results will shed light on the efficacy, safety, and tolerability of these drugs for endotracheal intubation.

Conclusion: The study aims to identify the most suitable neuromuscular blocking agent for facilitating endotracheal intubation by comparing atracurium and different doses of cis-atracurium. By assessing their onset, duration, recovery time, hemodynamic effects, and side effect profiles, clinicians can make informed decisions to optimize patient care during general anesthesia.

Downloads

Download data is not yet available.

References

Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth. 2007;98(3):302-16. doi: 10.1093/bja/ael386, PMID 17307778.

Miller RD. Neuromuscular blocking drugs. In: Miller RD, editor. Miller’s anesthesia. 9th ed. Elsevier; 2019. p. 864-90.

Naguib M, Lien CA. Pharmacology of muscle relaxants and their antagonists. In: Naguib M, Lien CA, editors. Clinical anesthesia. 8th ed. Lippincott Williams & Wilkins; 2017. p. 231-66.

Mencke T, Schmartz D, Fuchs Buder T. Neuromuscular monitoring. Anaesthesist. 2013;62(10):847-61. doi: 10.1007/s00101-013-2244-0. PMID 24150775.

Kisor DF, Schmith VD, Wargin WA. Pharmacokinetics and pharmacodynamics of atracurium besylate in patients with normal or impaired renal function. Anesthesiology. 1984;61(6):683-7.

Brandom BW, Woelfel SK, Cook DR, Stiller RL, Bacon DR. Histamine release during administration of atracurium or vecuronium in pediatric patients. Anesthesiology. 1985;63(5):494-7.

Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology. 2008;109(3):389-98. doi: 10.1097/ALN.0b013e318182af3b, PMID 18719436.

Fuchs Buder T, Meistelman C. Atracurium: an overview. J Clin Anesth. 1991 Nov-Dec;3(6):442-58.

de Boer HD, Driessen JJ, Marcus MA. Sugammadex and reversal of neuromuscular blockade: a systematic review and meta-analysis. Eur J Anaesthesiol. 2017 Nov;34(11):781-91.

Claudius C, Garvey LH, Viby Mogensen J. The undesirable effects of neuromuscular blocking drugs. Anaesthesia. 2009 Oct;64Suppl 1:10-21. doi: 10.1111/j.1365-2044.2008.05866.x, PMID 19222427.

Baumuller E, Schaller SJ. Neuromuscular monitoring: old issues, new debates. Curr Anesthesiol Rep. 2017;7(2):154-63.

Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Saf. 1998;19(3):173-89. doi: 10.2165/00002018-199819030-00002. PMID 9747665.

Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Anal. 2007;104(3):575-81. doi: 10.1213/01.ane.0000244594.63318.fc. PMID 17312211.